middle.news
Control Bionics Secures $10 Million to Accelerate Neurotechnology Growth
10:40am on Thursday 25th of June, 2026 AEST
•
Healthcare
Read Story
Control Bionics Secures $10 Million to Accelerate Neurotechnology Growth
10:40am on Thursday 25th of June, 2026 AEST
Key Points
Placement priced at $0.075 per share, 14.5% discount to VWAP
Two-tranche placement with second tranche needing shareholder approval
Directors to receive shares subject to approval
SPP offers eligible shareholders up to $30,000 at placement price
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Control Bionics (ASX:CBL)
OPEN ARTICLE